INDIA GLYCOLS LTD
INDIAGLYCO · General/Diversified · NSE
₹987
Current Market Price
Fair Value (DCF)
₹746
Discount to FV
-24.4%
Updated just now
YieldIQ Score
56/100
Piotroski F-Score
6/9
Economic Moat
None
Confidence
12%
ROE
10.0%
Debt/Equity
0.58
WACC
11.1%
Market Cap
₹6,613 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
15.1%
Return on capital employed
EV / EBITDA
10.5×
Enterprise multiple
Debt / EBITDA
2.6×
Leverage vs earnings
Interest Coverage
3.1×
EBIT covers interest
Current Ratio
0.78×
Short-term liquidity
Asset Turnover
1.59×
Revenue per ₹ of assets
Revenue CAGR (3Y)
17.8%
3-year revenue growth
Revenue CAGR (5Y)
-5.0%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹986.65
Bear case
Discount -123.3%
Base case
Discount -32.2%
Bull case
Discount +9.7%
Ratio Trends
INDIAGLYCO · last 9 annual periods
ROE
10.0%
ROCE
15.1%
Operating Margin
—
Debt / Equity
0.58×
PE
19.4×
EV / EBITDA
10.5×
Historical Financials
INDIAGLYCO · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹2813 Cr | ₹2577 Cr | ₹3269 Cr | ₹3768 Cr | ₹4211 Cr | +10.6% |
| EBITDA | ₹507 Cr | ₹344 Cr | ₹429 Cr | ₹572 Cr | ₹700 Cr | +8.4% |
| EBIT | ₹418 Cr | ₹254 Cr | ₹327 Cr | — | — | -5.9% |
| PAT | ₹340 Cr | ₹125 Cr | ₹173 Cr | ₹231 Cr | ₹293 Cr | -3.7% |
| EPS (diluted) | ₹106.45 | ₹45.55 | ₹55.87 | — | — | -14.9% |
| CFO | ₹116 Cr | ₹326 Cr | ₹439 Cr | ₹362 Cr | ₹769 Cr | +60.5% |
| CapEx | ₹-380 Cr | ₹-439 Cr | ₹-553 Cr | ₹-760 Cr | ₹-823 Cr | — |
| FCF | ₹-264 Cr | ₹-113 Cr | ₹-114 Cr | ₹-398 Cr | ₹-54.3 Cr | — |
| Total Assets | ₹4631 Cr | ₹4858 Cr | ₹5617 Cr | ₹6176 Cr | ₹6523 Cr | +8.9% |
| Total Debt | ₹1042 Cr | ₹1112 Cr | ₹1348 Cr | ₹1892 Cr | ₹1691 Cr | +12.9% |
| Shareholders' Equity | ₹1792 Cr | ₹1901 Cr | ₹2051 Cr | ₹2256 Cr | ₹2933 Cr | +13.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
INDIAGLYCO vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 GNFC GNFC | — | — | Pending | 8.9% | 6.7× |
ACI ACI | — | — | Pending | 5.5% | — |
GUJALKALI GUJALKALI | — | — | Pending | -0.0% | — |
 EPIGRAL EPIGRAL | — | — | Pending | 14.9% | — |
 DEEPAKFERT DEEPAKFERT | — | — | Pending | 10.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
10 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹27.00/sh
Last payout
2026-03-23
₹7.50
Peak payout
₹7.50
Trailing yield
1.27%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. INDIA GLYCOLS LTD (INDIAGLYCO.NS) trades at 986.65 vs a model fair value of 746.27, a gap of -24.4%. Piotroski F-score: 6/9. Moat label: ...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of INDIAGLYCO →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for INDIAGLYCO →
Compare
Head-to-head with peers
Compare INDIAGLYCO side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse INDIAGLYCONow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.